Buscar
Zoetis Inc
ZTSAñadir a la lista de seguimiento
77.280USD
+1.250+1.64%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
32.48BCap. mercado
12.79P/E TTM
Más Datos de Zoetis Inc Compañía
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Información de Zoetis Inc
Símbolo de cotizaciónZTS
Nombre de la empresaZoetis Inc
Fecha de salida a bolsaFeb 01, 2013
Director ejecutivoPeck (Kristin C)
Número de empleados13800
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 01
Dirección10 Sylvan Way
CiudadPARSIPPANY
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07054
Teléfono19738227000
Sitio Webhttps://www.zoetis.com/
Símbolo de cotizaciónZTS
Fecha de salida a bolsaFeb 01, 2013
Director ejecutivoPeck (Kristin C)
Ejecutivos de Zoetis Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Zoetis Inc?
Los cinco principales accionistas de Zoetis Inc son: Ms. Kristin C. Peck
¿Cuál es la mayor fuente de ganancias de Zoetis Inc?
El 2026Q4, el segmento empresarial Parasiticides generó la ganancia más alta para Zoetis Inc, ascendiendo a 2.34B y representando el 24.73% de la ganancia total.